NASDAQ
Mirati Therapeutics, Inc. (MRTX) has a revenue compound annual growth rate of 473.19% over 5 years and 139.41% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.